Sandoz Scores Regional First With EU Launch Of Autoinjectable Stelara Rival
The Approved Autoinjector Presentation Puts Sandoz Ahead Of Competition
Doubling down on the launch of its Stelara biosimilar Pyzchiva in Europe last year, Sandoz has just released an autoinjectable version of the drug, with the aim to offer a more convenient option for ustekinumab patients.
